دورية أكاديمية
Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.
| العنوان: | Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams. |
|---|---|
| المؤلفون: | Mohammed YH; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Brisbane, Australia. Y.Mohammed@uq.edu.au.; School of Pharmacy, The University of Queensland, Woolloongabba, QLD, 4102, Australia. Y.Mohammed@uq.edu.au., Namjoshi SN; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Brisbane, Australia., Jung N; Institute of Pharmaceutical Technology, Goethe University, Frankfurt, Germany., Windbergs M; Institute of Pharmaceutical Technology, Goethe University, Frankfurt, Germany., Benson HAE; Curtin Medical School, Curtin University, Perth, WA, Australia., Grice JE; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Brisbane, Australia., Raney SG; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Roberts MS; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Brisbane, Australia.; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.; Therapeutics Research Centre, Basil Hetzel Institute for Translational Medical Research, The Queen Elizabeth Hospital, Adelaide, Australia. |
| المصدر: | Pharmaceutical research [Pharm Res] 2024 Jul; Vol. 41 (7), pp. 1507-1520. Date of Electronic Publication: 2024 Jul 02. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 1999- : New York, NY : Kluwer Academic/Plenum Publishers Original Publication: Stuttgart ; New York : Thieme, c1984- |
| مواضيع طبية MeSH: | Acyclovir*/pharmacokinetics , Acyclovir*/administration & dosage , Skin Cream*/pharmacokinetics , Skin Cream*/chemistry , Skin Absorption* , Biological Availability* , Antiviral Agents*/pharmacokinetics , Antiviral Agents*/administration & dosage , Antiviral Agents*/chemistry , Therapeutic Equivalency*, Humans ; Administration, Cutaneous ; Skin/metabolism |
| مستخلص: | Purpose: To develop a toolkit of test methods for characterizing potentially critical quality attributes (CQAs) of topical semisolid products and to evaluate how CQAs influence the rate and extent of active ingredient bioavailability (BA) by monitoring cutaneous pharmacokinetics (PK) using an In Vitro Permeation Test (IVPT). Methods: Product attributes representing the physicochemical and structural (Q3) arrangement of matter, such as attributes of particles and globules, were assessed for a set of test acyclovir creams (Aciclostad® and Acyclovir 1A Pharma) and compared to a set of reference acyclovir creams (Zovirax® US, Zovirax® UK and Zovirax® Australia). IVPT studies were performed with all these creams using heat-separated human epidermis, evaluated with both, static Franz-type diffusion cells and a flow through diffusion cell system. Results: A toolkit developed to characterize quality and performance attributes of these acyclovir topical cream products identified certain differences in the Q3 attributes and the cutaneous PK of acyclovir between the test and reference sets of products. The cutaneous BA of acyclovir from the set of reference creams was substantially higher than from the set of test creams. Conclusions: This research elucidates how differences in the composition or manufacturing of product formulations can alter Q3 attributes that modulate myriad aspects of topical product performance. The results demonstrate the importance of understanding the Q3 attributes of topical semisolid drug products, and of developing appropriate product characterization tests. The toolkit developed here can be utilized to guide topical product development, and to mitigate the risk of differences in product performance, thereby supporting a demonstration of bioequivalence (BE) for prospective topical generic products and reducing the reliance on comparative clinical endpoint BE studies. (© 2024. The Author(s).) |
| References: | Clin Pharmacol. 2016 Oct 19;8:163-176. (PMID: 27799831) Pharm Res. 1998 Aug;15(8):1182-8. (PMID: 9706047) Adv Drug Deliv Rev. 2022 Jul;186:114293. (PMID: 35483435) J Pharm Sci. 2011 Mar;100(3):949-63. (PMID: 21280051) Dermatol Clin. 2022 Jul;40(3):319-332. (PMID: 35750415) AAPS J. 2013 Jan;15(1):41-52. (PMID: 23054971) Adv Drug Deliv Rev. 2021 Oct;177:113929. (PMID: 34403750) BMC Dermatol. 2009 Apr 02;9:3. (PMID: 19341466) Int J Pharm. 2014 Nov 20;475(1-2):110-22. (PMID: 25089511) Int J Pharm. 2005 Nov 4;304(1-2):63-71. (PMID: 16139970) Arch Dermatol. 1963 Dec;88:702-5. (PMID: 14071437) Pharm Res. 2022 May;39(5):935-948. (PMID: 35411509) Clin Pharmacol Ther. 2022 May;111(5):1036-1049. (PMID: 34231211) Pharm Res. 2014 Dec;31(12):3529-37. (PMID: 25005736) J Pharm Sci. 2005 May;94(5):1039-47. (PMID: 15793815) Mol Pharm. 2022 Sep 5;19(9):3139-3152. (PMID: 35969125) Dermatol Clin. 2022 Jul;40(3):279-287. (PMID: 35750411) PLoS One. 2016 Aug 22;11(8):e0160973. (PMID: 27548780) Pharm Res. 2016 Sep;33(9):2180-94. (PMID: 27312087) Pharmaceutics. 2020 Mar 23;12(3):. (PMID: 32210126) |
| معلومات مُعتمدة: | U01 FD005226 United States FD FDA HHS; U01FD005226 U.S. Food and Drug Administration |
| فهرسة مساهمة: | Keywords: in-vitro; IVPT; Q3; bioavailability; bioequivalence; cutaneous pharmacokinetics; topical |
| المشرفين على المادة: | X4HES1O11F (Acyclovir) 0 (Antiviral Agents) |
| تواريخ الأحداث: | Date Created: 20240702 Date Completed: 20240722 Latest Revision: 20240725 |
| رمز التحديث: | 20240726 |
| مُعرف محوري في PubMed: | PMC11263457 |
| DOI: | 10.1007/s11095-024-03736-9 |
| PMID: | 38955999 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1573-904X |
|---|---|
| DOI: | 10.1007/s11095-024-03736-9 |